<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01199276</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-08-C2-020</org_study_id>
    <nct_id>NCT01199276</nct_id>
  </id_info>
  <brief_title>Hip Fracture Surgery in Elderly Patients</brief_title>
  <acronym>HIPELD</acronym>
  <official_title>An International, Multi-center, Randomized, Controlled Trial Evaluating The Effect of Xenon on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>OptumInsight</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the incidence of Post-Operative Delirium (POD),
      diagnosed with the Confusion Assessment Method (CAM), in elderly patients undergoing hip
      fracture surgery under general anaesthesia with xenon or sevoflurane, for a period of four
      days post-surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Operative Delirium diagnosed with the Confusion Assessment Method within four days post-surgery</measure>
    <time_frame>Four days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post Operative Delirium diagnosed with the Confusion Assessment Method from day 5 post surgery to discharge from hospital</measure>
    <time_frame>About 7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sequential Organ Failure Assessment from day 1 to day 4 post-surgery</measure>
    <time_frame>four days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Parameters</measure>
    <time_frame>fifteen minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>economic parameters</measure>
    <time_frame>up to thirty days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Parameters</measure>
    <time_frame>Up to thirty days</time_frame>
    <description>Serious Adverse Events, Adverse Events, laboratory parameters</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">256</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Xenon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>60%(1MAC)in oxygen (FiO2 = 0.35-0.45)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.1-1.4% (1 MAC) in oxygen (FiO2 = 0.35-0.45) and medical air</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xenon</intervention_name>
    <description>Group A: xenon 60% (55%-65%)(1 MAC) in oxygen (FiO2 = 0.35-0.45)</description>
    <arm_group_label>Xenon</arm_group_label>
    <other_name>LENOXe</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Group B: sevoflurane 1.1-1.4%(1 MAC) in oxygen (FiO2 = 0.35-0.45) and Medical air</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elderly patient (≥ 75 years)

          -  Patient with planned hip fracture surgery within 48 hours after the hip fracture

          -  Patient willing and able to complete the requirements of this study including the
             signature of the written informed consent

        Exclusion Criteria:

          -  Patient suffering from multiple fractures, pelvic fractures proximal, pathological
             fractures, femur fractures (i.e., fractures of the middle or distal femur)

          -  Disabling neuropsychiatric disorders (severe dementia, Alzheimer's disease,
             schizophrenia, depression)

          -  Brain trauma within 12 months prior to selection, history of stroke with residuals

          -  Patient suffering from delirium (CAM diagnosis) at selection

          -  Patient who cannot complete the pre-operative mental tests (CAM and/or MMSE) of this
             clinical trial

          -  Patient with Mini-Mental State Examination (MMSE) score &lt; 24 at selection

          -  Patient known to susceptible to malignant hyperthermia

          -  Patient with elevated intra-cranial pressure

          -  Patient with a risk of high oxygen demand

          -  Patient with recent or ongoing myocardial infarction / damage

          -  Patient with severe cardiac failure, or patient with severe impaired left ventricular
             systolic function

          -  Patient with known severe lung and/or airway disease, or severe chronic respiratory
             insufficiency, or a sustained homecare oxygen therapy

          -  Contra-indication (serious illness or medical conditions) for general anaesthesia

          -  Known allergy or hypersensitivity to any drugs administered during this clinical trial

          -  Previous participation in this clinical trial

          -  Participation in another clinical trial within 4 weeks prior to selection

          -  History of alcohol or drug abuse or psychiatric disorders which would impair the
             understanding of the necessary information or render medically or legally unable to
             give written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark COBURN, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Aachen - Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert SANDERS, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Imperial College London - UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rolf ROSSAINT, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Aachen - Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Grenoble</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier COCHIN</name>
      <address>
        <city>Paris cedex 14</city>
        <zip>75979</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier La Pitié-Salpêtriere</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Pontchaillou - Université de Rennes 1</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>. Klinik für Anästhesiologie - Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Mutterhaus Der Borromaerinnen</name>
      <address>
        <city>Trier</city>
        <zip>54290</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Rizzoli Orthopaedic Institute</name>
      <address>
        <city>Bologna</city>
        <zip>40136</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imperial College NHS Trust</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2010</study_first_submitted>
  <study_first_submitted_qc>September 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2010</study_first_posted>
  <last_update_submitted>July 24, 2015</last_update_submitted>
  <last_update_submitted_qc>July 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Delirium</keyword>
  <keyword>Hip Fracture</keyword>
  <keyword>Elderly</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Xenon</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

